Better Choice Company

Canaccord Genuity Acts as Lead Agent for a US$17.2 Million Private Placement of Common Stock and Warrants for Better Choice Company, Inc.

Canaccord Genuity is pleased to announce that on May 6, 2019, Better Choice Company, Inc. (“BCC” or the “Company”) (OTCPK:BTTR) (OTCQB:SENZ) completed a private placement of common stock and warrants (the “Offering”), for total gross proceeds of approximately US$17.2 million.  The Company intends to use the net proceeds from this Offering for general corporate purposes and working capital.

Prior to the Offering, Canaccord was retained as a financial advisor to Bona Vida, Inc. (“Bona Vida”), an innovative emerging CBD platform, on its acquisition by BCC. Concurrently, BCC entered into a definitive agreement to acquire TruPet LLC (“TruPet”), an online seller of pet foods, nutritional pet products and related pet supplies. The Offering closed in conjunction with BCC’s acquisitions of Bona Vida and TruPet.

BCC is developing a portfolio of brand and product verticals within the animal and adult health space to become the preeminent player in the global hemp-derived CBD industry. BCC sources CBD from industrial hemp and acts exclusively as a contract manufacturer with no cultivation, processing or retail exposure.

Canaccord Genuity acted as lead agent for the transaction. The Canaccord Genuity team included Dan Daviau, Tom Pollard, Jennifer Pardi, Will Habos, Michael Wright, Or Barak, Tiffany Loh and Brooke Szczygiel.